Sugi Predict

Sugi Predict / Compounds / SCHEMBL2360372

SCHEMBL2360372

SCHEMBL2360372

O=[N+]([O-])c1ccccc1Sc1c([N+](=O)[O-])c([N+](=O)[O-])c([N+](=O)[O-])c([N+](=O)[O-])c1[N+](=O)[O-]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 2/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ SLC6A2 P23975 1/20 0.49
▸ SLC6A4 P31645 1/20 0.49
▸ SLC6A3 Q01959 1/20 0.49
▸ ALDH1A1 P00352 6/20 0.48
▸ HTT P42858 2/20 0.48
▸ MAPT P10636 6/20 0.46
▸ LMNA P02545 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ PKM P14618 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KDM4A O75164 1/20 0.44
▸ TDP2 O95551 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ KDM4C Q9H3R0 1/20 0.44
▸ APOBEC3G Q9HC16 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31272173 0.84 PDE7A (0.78) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL875772 0.84 PDE7A (0.78) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL2355829 0.80 PDE7A (0.57) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL6930370 0.79 PDE7A (0.59) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL30338244 0.77 PDE7A (0.65) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL1713219 0.77 PDE7A (0.65) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL224666 0.76 PDE7A (0.60) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL9709555 0.75 PDE7A (0.58) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL3192750 0.75 GPR35 (0.57) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL8095611 0.74 PDE7A (1.00) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064241-A1 PRIMARY EXPLOSIVES AND PRIMERS WHICH CAN BE IGNITED BY ELECTRIC TRIGGERING Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) 2001-01-03 — — EP claimed
WO-1999048842-A1 PRIMARY EXPLOSIVES AND PRIMERS WHICH CAN BE IGNITED BY ELECTRIC TRIGGERING DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) 1999-09-30 — — WO claimed
EP-0769309-A2 Extinguishing chain for fighting fires Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) 1997-04-23 — — EP claimed
US-4145969-A Priming system for high-temperature stable propellants DYNAMIT NOBEL AG (DE) 1979-03-27 — — US claimed
CN-121639739-B Multi-target tracking method for complex scene 北方工业大学 2026-05-12 — — CN disclosed
US-12566925-B2 Dialogue state aware dialogue summarization ADOBE INC. (US) 2026-03-03 — — US disclosed
US-12551496-B2 Betalain compositions and methods therefor VDF FUTURECEUTICALS, INC. (US) 2026-02-17 — — US disclosed
US-20250205169-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES, AND METHODS OF SYNTHESIS AND USE THEREOF TIDAL THERAPEUTICS, INC. 2025-06-26 — — US disclosed
CN-119377168-B Network-on-chip construction method, device, equipment and readable storage medium 北京开源芯片研究院 2025-03-07 — — CN disclosed
WO-2025042900-A1 MESSENGER RNA TREATMENT FOR SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY WASHINGTON STATE UNIVERSITY (US) 2025-02-27 — — WO disclosed
US-20250064900-A1 MESSENGER RNA TREATMENT FOR SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY WASHINGTON STATE UNIVERSITY 2025-02-27 — — US disclosed
CN-119377168-A Network-on-chip construction method, device, equipment and readable storage medium 北京开源芯片研究院 2025-01-28 — — CN disclosed
EP-0031045-B1 USE OF ZINC PEROXIDE AS OXIDISING AGENT IN EXPLOSIVES AND PYROTECHNIC COMPOSITIONS HÜLS TROISDORF AKTIENGESELLSCHAFT (DE) 1984-03-14 — — EP disclosed
US-4363679-A Use of zinc peroxide as oxidant for explosives and pyrotechnical mixtures DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) 1982-12-14 — — US disclosed
US-4336085-A MODIFYING THE DETONATION VELOCITY WALKER FRANKLIN E 1982-06-22 — — US disclosed
US-4304614-A AMMUNITION, DYNAMIC LASERS, FUSES, WELDING WALKER FRANKLIN E 1981-12-08 — — US disclosed
EP-0031045-A2 Use of zinc peroxide as oxidising agent in explosives and pyrotechnic compositions HÜLS TROISDORF AKTIENGESELLSCHAFT (DE) 1981-07-01 — — EP disclosed
US-4196026-A LOW MOLECULAR WEIGHT WALKER FRANKLIN E 1980-04-01 — — US disclosed
US-4145969-A Priming system for high-temperature stable propellants DYNAMIT NOBEL AG (DE) 1979-03-27 — — US disclosed
US-4142927-A ISOCYANATES, OLEFINS OR IODINE AS SCAVENGERS WALKER FRANKLIN E 1979-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12551496-B2 Betalain compositions and methods therefor SLC6A12, TNF, CTNND1 PDE7A 1579/4885SMN1; SMN2 2474/4885SLC6A2 621/4885
US-12566925-B2 Dialogue state aware dialogue summarization DIS3, TARDBP, TARBP1 PDE7A 1681/4885SMN1; SMN2 3392/4885SLC6A2 1313/4885
US-20250205169-A1 IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES, AND METHODS OF SYNTHESIS AND USE THEREOF LIPA, PHOSPHO1, SGMS1 PDE7A 2383/4885SMN1; SMN2 4022/4885SLC6A2 1938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.